Clinical Trial Update: Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen [Phase 3]

View source ↗

Summary

Phase 3 trial updating neurological monitoring for patients switching from dolutegravir to bictegravir-based regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir-based regimen (bictegravir)
• Dolutegravir-based regimen (dolutegravir)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Senese | Conditions: HIV-1-infection | Phase 3 | Status: UNKNOWN